Research-informed education, independent testing, and practical guidance across the evolving science and application of molecular hydrogen.
Explore H2HUBB articles covering molecular hydrogen research, hydrogen water, hydrogen inhalation, dosing, product testing, safety, technology, and practical education for consumers and the hydrogen industry.
In 82 patients with stage III and IV cancer treated with hydrogen inhalation using the "real world evidence" method, of the 58 cases with one or more abnormal tumor markers elevated, the markers were decreased at 13-45 days (median 23 days) after…
Read ArticleIn 49 patients, qOL scores during radiotherapy were significantly improved in patients treated with hydrogen-rich water compared to patients receiving placebo water. These findings add human evidence supporting…
Read ArticleIn CASE SUMMARY: The patient refused other treatments and began daily hydrogen inhalation therapy, three months after hydrogen therapy, the metastases in the abdominal cavity gradually reduced in…
Read ArticleH2HUBB TAKEAWAY This human study examined the present study was conducted to investigate the protective effect of hydrogen-rich water on the liver function of colorectal cancer (CRC) patients…
Read ArticleIn participants with radiotherapy or concurrent chemo-radiotherapy, qoL improved in the HW group (p = 0.03), while OFC scores showed no significant difference between groups (p = 0.74).…
Read ArticleIn Participants in hydrogen (H) group that inhaled hydrogen experienced quicker alleviation of postoperative brain edema compared with participants in control (C) group that inhaled oxygen,, hydrogen/oxygen inhalation…
Read ArticleIn 20 patients, after 2 weeks of hydrogen therapy, the number of exhausted and senescent cytotoxic T cells decreased to within the normal range, and there was an…
Read ArticleIn 55 patients, hydrogen gas decreased the abundance of exhausted terminal PD‐1+ CD8+ T cells, increased that of active terminal PD‐1‐ CD8+ T cells, and improved PFS and…
Read ArticleIn participants with systemic lupus erythematosus (SLE), this case study suggests that molecular hydrogen therapy may be a promising treatment for patients with SLE-PAH, particularly due to its…
Read ArticleIn 1 patients, iL-6 levels in the H₂ group significantly decreased in 4 weeks by 37.3 ± 62.0% compared to baseline, whereas it increased by 33.6 ± 34.4%…
Read ArticleThe results suggest that the hydroxyl radical scavenger H₂ effectively reduces oxidative stress in patients with this condition. These findings add human evidence supporting molecular hydrogen's therapeutic potential…
Read ArticleIn 3 patients, iL-17, whose concentration was high in Case 1, was reduced following H₂ treatment, and TNFα also decreased in Case 1. These findings add human evidence…
Read ArticleIn Methotrexate (MTX) remains a cornerstone of RA treatment, offering significant therapeutic benefits, this is the first case report to highlight severe MTX-induced myelosuppression in an RA patient…
Read ArticleThis human publication evaluated hydrogen gas in 8 patients with AD. This open-label, pilot study suggests therapeutic potential, while larger randomized, placebo-controlled studies are needed to confirm the…
Read ArticleIn 40 participants, a significant treatment vs. time interaction was found for telomere length (P = 0.049), with the length increased after HRW intervention (from 0.99 ± 0.15…
Read Article